Inventor · disambiguated record
Yeeman K. Ramtohul
Also filed as: RAMTOHUL YEEMAN · RAMTOHUL YEEMAN K
14 granted patents·20 pending applications·24 citations·filing 2006–2024
87Inventor score
Files withVERTEX PHARMA14MERCK FROSST CANADA LTD6ADURO BIOTECH INC2HORIZON THERAPEUTICS IRELAND DAC2LACHANCE NICOLAS2
Top patents by PatentIndex Score
34 records- 0183US7754745B2Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2007·Granted Jul 13, 2010·7 cites·15 claims
- 0282US8063224B2Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLACHANCE NICOLAS·Filed 2007·Granted Nov 22, 2011·10 cites·13 claims
- 0375US7582633B2Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA L L C·Filed 2008·Granted Sep 1, 2009·4 cites·19 claims
- 0474US2025179091A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0573US11634447B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2020·Granted Apr 25, 2023·0 cites·20 claims
- 0671US9598454B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Granted Mar 21, 2017·1 cites·17 claims
- 0770US7799787B2Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2006·Granted Sep 21, 2010·1 cites·6 claims
- 0869US10669298B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2018·Granted Jun 2, 2020·0 cites·20 claims
- 0967US10913761B22,7-dibromospiro[fluorene-9,4′-piperidine] compoundsVERTEX PHARMA·Filed 2020·Granted Feb 9, 2021·0 cites·12 claims
- 1065US9890176B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2014·Granted Feb 13, 2018·1 cites·22 claims
- 1164US12269831B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Apr 8, 2025·0 cites·41 claims
- 1263US2025145585A1Heterocyclic inhibitors of igf-1r for treatment of diseaseHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 1361US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1461US2025171431A1Heterocyclic inhibitors of igf-1r for treatment of diseaseHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 1556US12324802B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·53 claims
- 1656US9963478B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2016·Granted May 8, 2018·0 cites·32 claims
- 1756US2009270434A1Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLEBLANC YVES·Filed 2009·Application pending·0 cites
- 1850US2011152295A1Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLECLERC JEAN-PHILIPPE·Filed 2009·Application pending·0 cites
- 1950US2011166152A1Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLECLERC JEAN-PHILIPPE·Filed 2009·Application pending·0 cites
- 2049US2010249192A1Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2008·Application pending·0 cites
- 2148US2010197692A1Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2008·Application pending·0 cites
- 2247US2011021532A1Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2009·Application pending·0 cites
- 2347US2020181153A1Imidazopyridazinone compounds and uses thereofADURO BIOTECH INC·Filed 2019·Application pending·0 cites
- 2446US2010004245A1Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2007·Application pending·0 cites
- 2546US2019119282A1Imidazopyridazines useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2645US2010120784A1Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLACHANCE NICOLAS·Filed 2008·Application pending·0 cites
- 2743US2009291955A1Azacyclohexane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 DesaturaseCRANE SHELDON N·Filed 2006·Application pending·0 cites
- 2842US2009099200A1Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLI CHUN SING·Filed 2006·Application pending·0 cites
- 2941US10030024B2Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathwayVERTEX PHARMA·Filed 2016·Granted Jul 24, 2018·0 cites·23 claims
- 3041US2013261077A1Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 3135US10738056B2Pyrazolopyrimidinone compounds and uses thereofADURO BIOTECH INC·Filed 2018·Granted Aug 11, 2020·0 cites·35 claims
- 3231US2018057505A1Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 3330US2012035214A1Renin inhibitorsMCKAY DANIEL J·Filed 2010·Application pending·0 cites
- 3427US2011301143A1Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseISABEL ELISE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yeeman K. Ramtohul files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →